{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T05:16:01Z","timestamp":1787030161496,"version":"build-2736575974"},"reference-count":24,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2022,4,30]],"date-time":"2022-04-30T00:00:00Z","timestamp":1651276800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>Hepatitis C Virus (HCV) genotype (GT) 6 demonstrates maximum genomic diversity out of all the known genotypes of HCV, attributable to its inherent intra-genotype and inter-genotype recombination property. This is the most common genotype seen in HCV\/HIV co-infected cases. HIV\/HCV co-infection is linked with increased genetic diversity in HCV structural genes. The detailed information on the distribution of HCV GT6, its subtypes, and resistance to currently available antiviral drugs is limited in the Indian subcontinent. Therefore, in this single-center retrospective cross-sectional study, we aimed to map the occurrence of HCV GT6, its subtypes and resistance-associated substitution (RAS), and its correlation with antiviral treatment response in HCV-infected patients. From a cohort of 2052 HCV-infected patients, the overall prevalence of GT6 was 2.5% (n = 53), with a maximum of 81.1% (n = 43) seen in HCV\/HIV co-infected patients. Nine different subtypes, 6a, 6b, 6f, 6i, 6n, 6u, 6v, 6w, and 6xa, were detected in the Indian population for the first time, with a predominance of 6xa (41.5%), a rare subtype, followed by 6n (39.6%). The phylogenetic analysis by the neighbor-joining method revealed three prominent viral clades, 6v, 6n, and 6xa\u20136u. The baseline (before treatment initiation) plasma samples of all GT6-infected patients were retrieved from \u221280 \u00b0C and a part of the NS5a and NS5b region of the viral genome was analyzed for the presence of RAS. No RASs were seen in the NS5b region, while in two patients (3.7%) RASs were seen at baseline in the NS5a region of the virus. Sustained viral response (SVR) was attained in 81% (n = 43) of patients. No difference in GT6 subtype distribution or occurrence of RAS was seen between mono-infected HCV and HIV\/HCV co-infected cases. Our study revealed that RAS at baseline did not influence the attainment of SVR and the currently available antiviral therapy is effective against GT6 mono-infected and HIV\/HCV co-infected patients.<\/jats:p>","DOI":"10.3390\/v14050944","type":"journal-article","created":{"date-parts":[[2022,5,4]],"date-time":"2022-05-04T08:21:25Z","timestamp":1651652485000},"page":"944","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Treatment Response and Drug Resistance Profiling of Genotype 6 of Hepatitis C Virus in HCV\/HIV Co-Infected Patients: A Pilot Study from INDIA"],"prefix":"10.3390","volume":"14","author":[{"given":"Ekta","family":"Gupta","sequence":"first","affiliation":[{"name":"Department of Clinical Virology, Institute of Liver and Biliary Sciences, New Delhi 110070, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmine","family":"Samal","sequence":"additional","affiliation":[{"name":"Department of Clinical Virology, Institute of Liver and Biliary Sciences, New Delhi 110070, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Pandey","sequence":"additional","affiliation":[{"name":"Department of Clinical Virology, Institute of Liver and Biliary Sciences, New Delhi 110070, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaurav","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Clinical Virology, Institute of Liver and Biliary Sciences, New Delhi 110070, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajra A. S.","family":"Gupta","sequence":"additional","affiliation":[{"name":"Department of Innate Immunity, ICMR-National Institute for Research in Reproductive and Child Health, Mumbai 400012, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reshu","family":"Agarwal","sequence":"additional","affiliation":[{"name":"Department of Clinical Virology, Institute of Liver and Biliary Sciences, New Delhi 110070, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoj Kumar","family":"Sharma","sequence":"additional","affiliation":[{"name":"Department of Hepatology, Institute of Liver and Biliary Sciences, New Delhi 110070, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,4,30]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"7824","DOI":"10.3748\/wjg.v22.i34.7824","article-title":"Global epidemiology of hepatitis C virus infection: An up-date of the distribution and circulation of hepatitis C virus genotypes","volume":"22","author":"Petruzziello","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"5606","DOI":"10.1038\/s41598-019-41788-9","article-title":"Multidisciplinary Group of viral coinfection HIV\/Hepatitis (COVIHEP). HCV-coinfection is related to an increased HIV-1 reservoir size in cART-treated HIV patients: A cross-sectional study","volume":"9","author":"Palladino","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s12954-019-0346-y","article-title":"HIV\/HCV co-infection and associated risk factors among injecting drug users in Dar es Salaam, Tanzania: Potential for HCV elimination","volume":"16","author":"Leyna","year":"2019","journal-title":"Harm Reduct. J."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Ngwaga, T., Kong, L., Lin, D., Schoborg, C., Taylor, L.E., Mayer, K.H., Klein, R.S., Celentano, D.D., Sobel, J.D., and Jamieson, D.J. (2020). Diversity of the hepatitis C virus NS5B gene during HIV co-infection. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0237162"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1177\/1756283X09339079","article-title":"Predicting the probable outcome of treatment in HCV patients","volume":"2","author":"Navaneethan","year":"2009","journal-title":"Therap. Adv. Gastroenterol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/s12664-019-00934-x","article-title":"Genotype distribution in relation to viral load in a large cohort of Indian patients with chronic hepatitis C virus infection: A retrospective analysis","volume":"38","author":"Panyala","year":"2019","journal-title":"Indian J. Gastroenterol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"349","DOI":"10.4103\/0255-0857.118875","article-title":"Genotypes of hepatitis C virus in the Indian sub-continent: A decade-long experience from a tertiary care hospital in South India","volume":"31","author":"Christdas","year":"2013","journal-title":"Indian J. Med. Microbiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1007\/s00705-012-1374-z","article-title":"New insights into hepatitis C virus infection in the tribal-dominant part of Northeast India","volume":"157","author":"Medhi","year":"2012","journal-title":"Arch. Virol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/apt.15100","article-title":"Systematic review: Epidemiology and response to direct-acting antiviral therapy in genotype 6 chronic hepatitis C virus infection","volume":"49","author":"Mettikanont","year":"2019","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"e0029721","DOI":"10.1128\/Spectrum.00297-21","article-title":"Characterization of a Novel Hepatitis C Subtype, 6xj, and Its Consequences for Direct-Acting Antiviral Treatment in Yunnan, China","volume":"9","author":"Jia","year":"2021","journal-title":"Microbiol. Spectr."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.3748\/wjg.v20.i11.2927","article-title":"Hepatitis C virus genotype 6: Virology, epidemiology, genetic variation and clinical implication","volume":"20","author":"Thong","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.2147\/IDR.S301032","article-title":"Naturally Occurring Resistance Associated Substitutions in Non-Cirrhotic, Treatment Naive HCV-HIV Co-Infected Patients Does Not Affect the Treatment Response for Anti-HCV Antiviral Therapy","volume":"14","author":"Gupta","year":"2021","journal-title":"Infect. Drug Resist."},{"key":"ref_13","unstructured":"World Health Organization (2018). Guidelines for the Care and Treatment of Persons Diagnosed with Chronic Hepatitis C Virus Infection, World Health Organization."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jmii.2015.01.006","article-title":"Molecular characterization of hepatitis C virus genotype 6 subtypes in Thai blood donors","volume":"50","author":"Sistayanarain","year":"2017","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Bukowska-O\u015bko, I., Pawe\u0142czyk, A., Perlejewski, K., Kubisa, N., Caraballo Cort\u00e9s, K., Rosi\u0144ska, M., P\u0142oski, R., Fic, M., Ka\u017amierczak, J., and Popiel, M. (2015). Genetic Variability of Hepatitis C Virus (HCV) 5\u2032 Untranslated Region in HIV\/HCV Coinfected Patients Treated with Pegylated Interferon and Ribavirin. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0125604"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"376","DOI":"10.4103\/ijmm.IJMM_17_371","article-title":"Hepatitis C virus and its genotypes in chronic liver disease patients from Meghalaya, Northeast India","volume":"36","author":"Barman","year":"2018","journal-title":"Indian J. Med. Microbiol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1872-034X.2007.00053.x","article-title":"Hepatitis C virus genotype distribution in Myanmar: Predominance of genotype 6 and existence of new genotype 6 subtype","volume":"37","author":"Lwin","year":"2007","journal-title":"Hepatol. Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e95","DOI":"10.1038\/emi.2017.77","article-title":"Hepatitis C virus genotypes and subtypes circulating in Mainland China","volume":"6","author":"Chen","year":"2017","journal-title":"Emerg. Microbes Infect."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/jmv.21680","article-title":"Geographic distribution of hepatitis C virus genotype 6 subtypes in Thailand","volume":"82","author":"Akkarathamrongsin","year":"2010","journal-title":"J. Med. Virol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"348","DOI":"10.4103\/0971-5916.182626","article-title":"High burden of hepatitis C & HIV co-infection among people who inject drugs in Manipur, Northeast India","volume":"143","author":"Kermode","year":"2016","journal-title":"Indian J. Med. Res."},{"key":"ref_21","first-page":"640","article-title":"Risk of hepatitis C infection among injection drug users in Mizoram, India","volume":"128","author":"Chelleng","year":"2008","journal-title":"Indian J. Med. Res."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Malandris, K., Kalopitas, G., Theocharidou, E., and Germanidis, G. (2021). The Role of RASs\/RVs in the Current Management of HCV. Viruses, 13.","DOI":"10.3390\/v13102096"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Zar\u0119bska-Michaluk, D., Jaroszewicz, J., Parfieniuk-Kowerda, A., Paw\u0142owska, M., Janczewska, E., Berak, H., Janocha-Litwin, J., Klapaczy\u0144ski, J., Tomasiewicz, K., and Piekarska, A. (2022). Pangenotypic and Genotype-Specific Antivirals in the Treatment of HCV Genotype 4 Infected Patients with HCV Monoinfection and HIV\/HCV Coinfection. J. Clin. Med., 11.","DOI":"10.3390\/jcm11020389"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"ofab267","DOI":"10.1093\/ofid\/ofab267","article-title":"High Cure Rates for Hepatitis C Virus Genotype 6 in Advanced Liver Fibrosis with 12 Weeks Sofosbuvir and Daclatasvir: The Vietnam SEARCH Study","volume":"8","author":"Flower","year":"2021","journal-title":"Open Forum Infect. Dis."}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/14\/5\/944\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:05:08Z","timestamp":1760137508000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/14\/5\/944"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,30]]},"references-count":24,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2022,5]]}},"alternative-id":["v14050944"],"URL":"https:\/\/doi.org\/10.3390\/v14050944","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,30]]}}}